Results 181 to 190 of about 317,528 (279)

Rethinking Common Diagnoses: Idiopathic Multicentric Castleman Disease Presenting as TAFRO Syndrome: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Idiopathic multicentric Castleman disease (TAFRO subtype) can mimic common differentials. High suspicion is required for chronic systemic symptoms and generalized lymphadenopathy. As fine‐needle aspiration is often non‐diagnostic, early excisional biopsy is important.
Divita Rohatgi   +3 more
wiley   +1 more source

Disseminated Mixed Lytic‐Sclerotic Skeletal Metastases as Initial Presentation of Gallbladder Carcinoma: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Gallbladder carcinoma is an aggressive malignancy often diagnosed at an advanced stage. Skeletal metastasis, especially mixed lytic‐sclerotic lesions, is rare and typically occurs late. This report highlights an unusual presentation where widespread bony metastases were the initial manifestation, leading to the diagnosis of gallbladder ...
Shivali Rao   +2 more
wiley   +1 more source

Predicting Relevant Microglia‐Associated Cell–Cell Communication Pathways in Alzheimer's Disease: A Role for SPP1

open access: yesGlia, Volume 74, Issue 10, October 2026.
We used CellChat to infer altered cell–cell communication in Alzheimer's disease Microglia signal to each other via SPP1 in Alzheimer's disease. SPP1‐expressing microglia are present around amyloid‐β plaques. ABSTRACT Microglia play a key role in the pathophysiology of Alzheimer's Disease (AD) and their increased heterogeneity likely affects disease ...
Janssen M. Kotah   +7 more
wiley   +1 more source

Newly diagnosed and relapsed follicular lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow‐up

open access: yesHemaSphere, Volume 10, Issue 10, October 2026.
Abstract Follicular lymphoma (FL) is the second most common lymphoma subtype in Europe, with a median age at diagnosis of 60–65 years. It is generally considered an indolent disease, and the median overall survival at diagnosis now likely exceeds 20 years. However, considerable heterogeneity exists.
Marco Ladetto   +17 more
wiley   +1 more source

Healthcare Providers' Strategies to Improve Breast Cancer Screening Among South Asian Women in Victoria

open access: yesHealth Promotion Journal of Australia, Volume 37, Issue 4, October 2026.
ABSTRACT Background Participation in breast cancer screening among culturally diverse women in Australia remains below national targets. Healthcare providers, particularly general practitioners (GPs), play a pivotal role in bridging communication and knowledge gaps and in advocacy, especially for under‐screened South Asian (Pakistani and Indian) women.
Farwa Rizvi   +5 more
wiley   +1 more source

The TRPM2–PARP‐1 Axis Involvement in Bisphenol A and Nonylphenol‐Induced Ferroptosis in Trigeminal Ganglion Cells

open access: yesJournal of Applied Toxicology, Volume 46, Issue 10, Page 3660-3674, October 2026.
ABSTRACT Environmental contaminants like bisphenol A (BPA) and nonylphenol (NP) are recognized neurotoxicants; however, the molecular mechanisms underlying their impact on sensory ganglia, specifically the trigeminal ganglion (TG), remain critically underexplored.
Betül Yazğan   +3 more
wiley   +1 more source

Integrating ZooMS and taphonomy further highlights differential processing of animal and Neandertal carcasses in the Quina Mousterian at Les Pradelles (Marillac‐le‐Franc, southwest France)

open access: yesJournal of Quaternary Science, Volume 41, Issue 7, Page 1125-1140, October 2026.
ABSTRACT The cave of Les Pradelles (Marillac‐le‐Franc, France) was repeatedly visited by Neandertals ~55 000 years ago and is a key site in discussions of Neandertal cannibalism. Excavations between 1967 and 1980 (Vandermeersch) and between 2001 and 2013 (Maureille/Mann) produced a rich faunal assemblage (>20 000 bones), alongside Quina Mousterian ...
Pauline Raymond   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy